Introduction and perspective, historical note

Frontiers in Cellular Neuroscience

Volumn 7, Issue NOV, 2013, Pages

  Burnstock, Geoffrey ^a,b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Bladder; Brain; Cancer; Gut; Inflammation; Lung; Pain; Skin

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; NERVE GROWTH FACTOR ANTIBODY; PURINERGIC P2X RECEPTOR; PURINERGIC P2X RECEPTOR AGONIST; PURINERGIC P2X RECEPTOR ANTAGONIST; PURINERGIC P2X1 RECEPTOR; PURINERGIC P2X2 RECEPTOR; PURINERGIC P2X3 RECEPTOR; PURINERGIC P2X4 RECEPTOR; PURINERGIC P2X5 RECEPTOR; PURINERGIC P2X7 RECEPTOR; PURINERGIC P2Y RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; CELL DIFFERENTIATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL (TOPIC); CONGESTIVE CARDIOMYOPATHY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DUCHENNE MUSCULAR DYSTROPHY; EPIDERMIS HYPERPLASIA; HUMAN; IMMUNOMODULATION; IMMUNOREACTIVITY; INFLAMMATION; IRRITABLE COLON; KIDNEY POLYCYSTIC DISEASE; NEOPLASM; NEUROMODULATION; NONHUMAN; PATHOPHYSIOLOGY; PREECLAMPSIA; PROTEIN EXPRESSION; REVIEW; SMOOTH MUSCLE CONTRACTION; SPERMATOGENESIS; SPINAL CORD INJURY; TRAUMATIC BRAIN INJURY; VISCERAL PAIN;

EID: 84888353305     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2013.00227     Document Type: Review

References (192)

1. Abbracchio, M. P., and Burnstock, G. (1994). Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol. Ther. 64, 445-475. doi: 10.1016/0163-7258(94)00048-4
2. Abraham, E. H., Salikhova, A. Y., and Rapaport, E. (2003). ATP in the treatment of advanced cancer. Curr. Topics Membr. 54, 415-452. doi: 10.1016/S1063-5823(03)01013-5
3. Adinolfi, E., Melchiorri, L., Falzoni, S., Chiozzi, P., Morelli, A., Tieghi, A., et al. (2002). P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia. Blood 99, 706-708. doi: 10.1182/blood.V99.2.706
4. Adriaensen, D., and Timmermans, J. P. (2004). Purinergic signalling in the lung: important in asthma and COPD? Curr. Opin. Pharmacol. 4, 207-214. doi: 10.1016/j.coph.2004.01.010
5. Agboh, K. C., Webb, T. E., Evans, R. J., and Ennion, S. J. (2004). Functional characterization of a P2X receptor from Schistosoma mansoni. J. Biol. Chem. 279, 41650-41657. doi: 10.1074/jbc.M408203200
6. Agteresch, H. J., van Rooijen, M. H. C., van den Berg, J. W. O., Minderman-Voortman, G. J., Wilson, J. H. P., and Dagnelie, P. C. (2003). Growth inhibition of lung cancer cells by adenosine 5-triphosphate. Drug Dev. Res. 60, 196-203. doi: 10.1002/ddr.10296
7. Andries, M., Van Damme, P., Robberecht, W., and Van Den Bosch, L. (2007). Ivermectin inhibits AMPA receptor-mediated excitotoxicity in cultured motor neurons and extends the life span of a transgenic mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 25, 8-16. doi: 10.1016/j.nbd.2006.08.018
8. Antunes, V. R., Bonagamba, L. G., and Machado, B. H. (2005). Hemodynamic and respiratory responses to microinjection of ATP into the intermediate and caudal NTS of awake rats. Brain Res. 1032, 85-93. doi: 10.1016/j.brainres.2004.10.048
9. Apolloni, S., Amadio, S., Montilli, C., Volonté, C., and D'Ambrosi, N. (2013). Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis. Hum. Mol. Genet. 22, 4102-4116. doi: 10.1093/hmg/ddt259
10. Bailey, M. A., and Shirley, D. G. (2009). Effects of extracellular nucleotides on renal tubular solute transport. Purinergic Signal. 5, 473-480. doi: 10.1007/s11302-009-9149-z
11. Barden, N., Harvey, M., Gagné, B., Shink, E., Tremblay, M., Raymond, C., et al. (2006). Analysis of single nucleotide polymorphisms in genes in the chromo-some 12Q24.31 region points to P2RX7 as a susceptibility gene to bipolar affective disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141, 374-382. doi: 10.1002/ajmg.b.30303
12. Bardoni, R., Goldstein, P. A., Lee, C. J., Gu, J. G., and MacDermott, A. B. (1997). ATP P2X receptors mediate fast synaptic transmission in the dorsal horn of the rat spinal cord. J. Neurosci. 17, 5297-5304.
13. Baroni, M., Pizzirani, C., Pinotti, M., Ferrari, D., Adinolfi, E., Calzavarini, S., et al. (2007). Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticles. FASEB J. 21, 1926-1933. doi: 10.1096/fj.06-7238com
14. Bian, X., Ren, J., DeVries, M., Schnegelsberg, B., Cockayne, D. A., Ford, A. P., et al. (2003). Peristalsis is impaired in the small intestine of mice lacking the P2X3 subunit. J. Physiol. 551, 309-322. doi: 10.1113/jphysiol.2003.044172
15. Bo, X., Alavi, A., Xiang, Z., Oglesby, I., Ford, A., and Burnstock, G. (1999). Localization of ATP-gated P2X2 and P2X3 receptor immunoreactive nerves in rat taste buds. Neuroreport 10, 1107-1111. doi: 10.1097/00001756-199904060-00037
16. Bodin, P., and Burnstock, G. (2001). Purinergic signalling: ATP release. Neurochem. Res. 26, 959-969. doi: 10.1023/A:1012388618693
17. Boselli, C., Govoni, S., Condino, A. M., and D'Agostino, G. (2001). Bladder instability: a re-appraisal of classical experimental approaches and development of new therapeutic strategies. J. Auton. Pharmacol. 21, 219-229. doi: 10.1046/j.1365-2680.2001.00235.x
18. Brake, A. J., Wagenbach, M. J., and Julius, D. (1994). New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature 371, 519-523. doi: 10.1038/371519a0
19. Bulanova, E., Budagian, V., Orinska, Z., Koch-Nolte, F., Haag, F., and Bulfone-Paus, S. (2009). ATP induces P2X7 receptor-independent cytokine and chemokine expression through P2X1 and P2X3 receptors in murine mast cells. J. Leukoc. Biol. 85, 692-702. doi: 10.1189/jlb.0808470
20. Burnstock, G. (1978). "A basis for distinguishing two types of purinergic receptor," in Cell Membrane Receptors for Drugs and Hormones: A Multidisciplinary Approach, eds R. W. Straub and L. Bolis (New York, NY: Raven Press), 107-118.
21. Burnstock, G. (1989). The role of adenosine triphosphate in migraine. Biomed. Pharmacother. 43, 727-736. doi: 10.1016/0753-3322(89)90161-3
22. Burnstock, G. (1990). Noradrenaline and ATP as cotransmitters in sympathetic nerves. Neurochem. Int. 17, 357-368. doi: 10.1016/0197-0186(90)90158-P
23. Burnstock, G. (1999). Release of vasoactive substances from endothelial cells by shear stress and purinergic mechanosensory transduction. J. Anat. 194, 335-342. doi: 10.1046/j.1469-7580.1999.19430335.x
24. Burnstock, G. (2001a). "Purinergic signalling in lower urinary tract," in Handbook of Experimental Pharmacology, Vol. 151/I. Purinergic and Pyrimidinergic Signalling I-Molecular, Nervous and Urinogenitary System Function, eds M. P. Abbracchio and M. Williams (Berlin: Springer-Verlag), 423-515.
25. Burnstock, G. (2001b). Purine-mediated signalling in pain and visceral perception. Trends Pharmacol. Sci. 22, 182-188. doi: 10.1016/S0165-6147(00)01643-6
26. Burnstock, G. (2006a). Purinergic P2 receptors as targets for novel analgesics. Pharmacol. Therap. 110, 433-454. doi: 10.1016/j.pharmthera.2005.08.013
27. Burnstock, G. (2006b). Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol. Rev. 58, 58-86. doi: 10.1124/pr.58.1.5
28. Burnstock, G. (2007a). Purine and pyrimidine receptors. Cell. Mol. Life Sci. 64, 1471-1483. doi: 10.1007/s00018-007-6497-0
29. Burnstock, G. (2007b). Physiology and pathophysiology of purinergic neurotransmission. Physiol. Rev. 87, 659-797. doi: 10.1152/physrev.00043.2006
30. Burnstock, G. (2008a). Purinergic signalling and disorders of the central nervous system. Nature Revs. Drug Discovery 7, 575-590. doi: 10.1038/nrd2605
31. Burnstock, G. (2008b). The journey to establish purinergic signalling in the gut. Neurogastroenterol. Motil. 20, 8-19. doi: 10.1111/j.1365-2982.2008.01107.x
32. Burnstock, G. (2008c). Commentary. Purinergic receptors as future targets for treatment of functional GI disorders. Gut 57, 1193-1194. doi: 10.1136/gut.2008. 151134
33. Burnstock, G. (2009a). Purines and sensory nerves. Hndbk. Exp. Pharmacol. 194, 333-392. doi: 10.1007/978-3-540-79090-7_10
34. Burnstock, G. (2009b). Purinergic cotransmission. Exp. Physiol. 94, 20-24. doi: 10.1113/expphysiol.2008.043620
35. Burnstock, G. (2009c). Purinergic mechanosensory transduction and visceral pain. Mol. Pain 5, 69. doi: 10.1186/1744-8069-5-69
36. Burnstock, G. (2009d). Purinergic receptors and pain. Curr. Pharm. Des. 15, 1717-1735. doi: 10.2174/138161209788186335
37. Burnstock, G. (2012). P2X receptors in the gut. WIREs Membrane Transport and Signaling 1, 269-279. doi: 10.1002/wmts.16
38. Burnstock, G. (2013). Purinergic signalling in the lower urinary tract. Acta Physiologica 207, 40-52. doi: 10.1111/apha.12012
39. Burnstock, G., and Arnett, T. R. (2006). Edited Monograph: Nucleotides and Regulation of Bone Cell Function. Boca Raton, FL: Taylor & Francis Group.
40. Burnstock, G., Arnett, T. R., and Orriss, I. R. (2013). Purinergic signalling in the musculoskeletal system. Purinergic Signal. doi: 10.1007/s11302-013-9381-4. [Epub ahead of print].
41. Burnstock, G., Brouns, I., Adriaensen, D., and Timmermans, J. P. (2012a). Purinergic signalling in the airways. Pharmacol. Rev. 64, 834-868. doi: 10.1124/pr.111.005389
42. Burnstock, G., Knight, G. E., and Greig, A. V. H. (2012b). Purinergic signalling in healthy and diseased skin. J. Invest. Dermatol. 132, 526-546. doi: 10.1038/jid.2011.344
43. Burnstock, G., Cocks, T., Crowe, R., and Kasakov, L. (1978). Purinergic innervation of the guinea-pig urinary bladder. Br. J. Pharmacol. 63, 125-138. doi: 10.1111/j.1476-5381.1978.tb07782.x
44. Burnstock, G., and Di Virgilio, F. (2013). Purinergic signalling in cancer. Purinergic Signal. doi: 10.1007/s11302-013-9372-5. [Epub ahead of print].
45. Burnstock, G., and Kennedy, C. (1985). Is there a basis for distinguishing two types of P2-purinoceptor? Gen. Pharmacol. 16, 433-440. doi: 10.1016/03063623(85)90001-1
46. Burnstock, G., and Knight, G. E. (2004). Cellular distribution and functions of P2 receptor subtypes in different systems. Int. Rev. Cytol. 240, 31-304. doi: 10.1016/S0074-7696(04)40002-3
47. Burnstock, G., Krügel, U., Abbracchio, M. P., and Illes, P. (2011a). Purinergic signalling: from normal behaviour to pathological brain function. Prog. Neurobiol. 95, 229-274. doi: 10.1016/j.pneurobio.2011.08.006
48. Burnstock, G., Verkhratsky, A., and Fredholm, B. (2011b). Adenosine and ATP receptors in the brain. Curr. Top. Med. Chem. 11, 973-1011. doi: 10.2174/156802611795347627
49. Burnstock, G., and Novak, I. (2013). Purinergic signalling and diabetes. Purinergic Signal. 9, 307-324. doi: 10.1007/s11302-013-9359-2
50. Burnstock, G., and Verkhratsky, A. (2012a). Evolution of P2X receptors. WIREs Membrane Transport and Signaling 1, 188-200. doi: 10.1002/wmts.13
51. Burnstock, G., and Verkhratsky, A. (2012b). Purinergic Signalling and the Nervous System. Heidelberg; Berlin: Springer. doi: 10.1007/978-3-642-28863-0
52. Calvert, R. C., Shabbir, M., Thompson, C. S., Mikhailidis, D. P., Morgan, R., and Burnstock, G. (2004). Immunocytochemical and pharmacological characterisation of P2-purinoceptor-mediated cell growth and death in PC-3 hormone refractory prostate cancer cells. Anticancer Res. 24, 2853-2859.
53. Calvert, R. C., Thompson, C. S., and Burnstock, G. (2008). ATP release from the human ureter on distension and P2X3 receptor expression on suburothelial sensory nerves. Purinergic Signal. 4, 377-381. doi: 10.1007/s11302-008-9123-1
54. Cavaliere, F., Florenzano, F., Amadio, S., Fusco, F. R., Viscomi, M. T., D'Ambrosi, N., et al. (2003). Up-regulation of P2X2, P2X4 receptor and ischemic cell death: prevention by P2 antagonists. Neuroscience 120, 85-98. doi: 10.1016/S03064522(03)00228-8
55. Chen, C. C., Akopian, A. N., Sivilotti, L., Colquhoun, D., Burnstock, G., and Wood, J. N. (1995). A P2X purinoceptor expressed by a subset of sensory neurons. Nature 377, 428-431. doi: 10.1038/377428a0
56. Chess-Williams, R. (2004). Potential therapeutic targets for the treatment of detrusor overactivity. Expert. Opin. Ther. Targets. 8, 95-106. doi: 10.1517/14728222.8.2.95
57. Cockayne, D. A., Hamilton, S. G., Zhu, Q.-M., Dunn, P. M., Zhong, Y., Novakovic, S., et al. (2000). Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature 407, 1011-1015. doi: 10.1038/35039519
58. Collo, G., North, R. A., Kawashima, E., Merlo-Pich, E., Neidhart, S., Surprenant, A., et al. (1996). Cloning of P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels. J. Neurosci. 16, 2495-2507.
59. Coutinho-Silva, R., Parsons, M., Robson, T., and Burnstock, G. (2001). Changes in expression of P2 receptors in rat and mouse pancreas during development and aging. Cell Tissue Res. 306, 373-383. doi: 10.1007/s004410100458
60. Coutinho-Silva, R., Parsons, M., Robson, T., Lincoln, J., and Burnstock, G. (2003). P2X and P2Y purinoceptor expression in pancreas from streptozotocin-diabetic rats. Mol. Cell. Endocrinol. 204, 141-154. doi: 10.1016/S0303-7207(03)00003-0
61. Dang, K., Bielfeldt, K., Lamb, K., and Gebhart, G. F. (2005). Gastric ulcers evoke hyperexcitability and enhance P2X receptor function in rat gastric sensory neurons. J. Neurophysiol. 93, 3112-3119. doi: 10.1152/jn.01127.2004
62. D'Arco, M., Giniatullin, R., Simonetti, M., Fabbro, A., Nair, A., Nistri, A., et al. (2007). Neutralization of nerve growth factor induces plasticity of ATP-sensitive P2X3 receptors of nociceptive trigeminal ganglion neurons. J. Neurosci. 27, 8190-8201. doi: 10.1523/JNEUROSCI.0713-07.2007
63. Davies, D. L., Kochegarov, A. A., Kuo, S. T., Kulkarni, A. A., Woodward, J. J., King, B. F., et al. (2005). Ethanol differentially affects ATP-gated P2X3 and P2X4 receptor subtypes expressed in Xenopus oocytes. Neuropharmacology 49, 243-253. doi: 10.1016/j.neuropharm.2005.03.015
64. Dell'Antonio, G., Quattrini, A., Cin, E. D., Fulgenzi, A., and Ferrero, M. E. (2002). Relief of inflammatory pain in rats by local use of the selective P2X7 ATP receptor inhibitor, oxidized ATP. Arthritis Rheum. 46, 3378-3385. doi: 10.1002/art.10678
65. Denda, M., Inoue, K., Fuziwara, S., and Denda, S. (2002). P2X purinergic receptor antagonist accelerates skin barrier repair and prevents epidermal hyperplasia induced by skin barrier disruption. J. Invest. Dermatol. 119, 1034-1040. doi: 10.1046/j.1523-1747.2002.19505.x
66. Di Virgilio, F. (2007). Liaisons dangereuses: P2X7 and the inflammasome. Trends Pharmacol. Sci. 28, 465-472. doi: 10.1016/j.tips.2007.07.002
67. Di Virgilio, F. (2013). The therapeutic potential of modifying inflammasomes and NOD-like receptors. Pharmacol Rev 65, 872-905. doi: 10.1124/pr.112.006171
68. Di Virgilio, F., Ferrari, D., and Adinolfi, E. (2009). P2X7: a growthpromoting receptor-implications for cancer. Purinergic Signal. 5, 251-256. doi: 10.1007/s11302-009-9145-3
69. Diez-Zaera, M., Diaz-Hernandez, M., Alberch, J., Miras-Portugal, M. T., and Lucas, J. J. (2007). Purinergic system in Huntington's disease: develop of new therapeutic strategies. J. Neurochem. 101, 66.
70. Duarte, J. M., Oses, J. P., Rodrigues, R. J., and Cunha, R. A. (2007). Modification of purinergic signaling in the hippocampus of streptozotocin-induced diabetic rats. Neuroscience 149, 382-391. doi: 10.1016/j.neuroscience.2007.08.005
71. Dunn, P. M. (2000). Fertility: purinergic receptors and the male contraceptive pill. Curr. Biol. 10, R305-R307. doi: 10.1016/S0960-9822(00)00436-X
72. Edwards, F. A., Gibb, A. J., and Colquhoun, D. (1992). ATP receptor-mediated synaptic currents in the central nervous system. Nature 359, 144-147. doi: 10.1038/359144a0
73. Evans, R. J., Derkach, V., and Surprenant, A. (1992). ATP mediates fast synaptic transmission in mammalian neurons. Nature 357, 503-505. doi: 10.1038/357503a0
74. Fabbretti, E., D'Arco, M., Fabbro, A., Simonetti, M., Nistri, A., and Giniatullin, R. (2006). Delayed upregulation of ATP P2X3 receptors of trigeminal sensory neurons by calcitonin gene-related peptide. J. Neurosci. 26, 6163-6171. doi: 10.1523/JNEUROSCI.0647-06.2006
75. Facer, P., Knowles, C. H., Tam, P. K., Ford, A. P., Dyer, N., Baecker, P. A., et al. (2001). Novel capsaicin (VR1) and purinergic (P2X3) receptors in Hirschsprung's intestine. J. Pediatr. Surg. 36, 1679-1684. doi: 10.1053/jpsu.2001.27959
76. Ferrari, D., Munerati, M., Melchiorri, L., Hanau, S., Di Virgilio, F., and Baricordi, O. R. (1994). Responses to extracellular ATP of lymphoblastoid cell lines from Duchenne muscular dystrophy patients. Am. J. Physiol. 267, C886-C892.
77. Fountain, S. J., and Burnstock, G. (2009). An evolutionary history of P2X receptors. Purinergic Signal. 5, 269-272. doi: 10.1007/s11302-008-9127-x
78. Franke, H., Krügel, U., and Illes, P. (2006). P2 receptors and neuronal injury. Pflugers Arch. 452, 622-644. doi: 10.1007/s00424-006-0071-8
79. Franke, H., Verkhratsky, A., Burnstock, G., and Illes, P. (2012). Pathophysiology of astroglial purinergic signalling. Purinergic Signal. 8, 629-657. doi: 10.1007/s11302-012-9300-0
80. Fumagalli, M., Ceruti, S., Verderio, C., and Abbracchio, M. P. (2006). ATP as a neurotransmitter of pain in migraine: a functional role for P2Y receptors in primary cultures from mouse trigeminal sensory ganglia. Purinergic Signal. 2, 120-121.
81. Galligan, J. J. (2004). Enteric P2X receptors as potential targets for drug treatment of the irritable bowel syndrome. Br. J. Pharmacol. 141, 1294-1302. doi: 10.1038/sj.bjp.0705761
82. Gayle, S., and Burnstock, G. (2005). Immunolocalisation of P2X and P2Y nucleotide receptors in the rat nasal mucosa. Cell Tiss. Res. 319, 27-36. doi: 10.1007/s00441-004-0979-2
83. Gever, J., Cockayne, D. A., Dillon, M. P., Burnstock, G., and Ford, A. P. D. W. (2006). Pharmacology of P2X channels. Pflugers Arch. 452, 513-537. doi: 10.1007/s00424-006-0070-9
84. Gever, J. R., Rothschild, S., Henningsen, R., Martin, R., Hackos, D., Panicker, S., et al. (2010). AF-353, a novel, potent orally bioavailable P2X3/P2X2/3 receptor antagonist. Br. J. Pharmacol. 160, 1387-1398. doi: 10.1111/j.14765381.2010.00796.x
85. Glass, R., Bardini, M., Robson, T., and Burnstock, G. (2001). Expression of nucleotide P2X receptor subtypes during spermatogenesis in the adult rat testis. Cells Tiss. Org. 169, 377-387. doi: 10.1159/000047905
86. Gonzales, E. B., Kawate, T., and Gouaux, E. (2009). Pore architecture and ion sites in acid-sensing ion channels and P2X receptors. Nature 460, 599-604. doi: 10.1038/nature08218
87. Gorodeski, G. I. (2002). Regulation of transcervical permeability by two distinct P2 purinergic receptor mechanisms. Am. J. Physiol. Cell Physiol. 282, C75-C83.
88. Gourine, A. V., Atkinson, L., Deuchars, J., and Spyer, K. M. (2003). Purinergic signalling in the medullary mechanisms of respiratory control in the rat: respiratory neurones express the P2X2 receptor subunit. J. Physiol. 552, 197-211. doi: 10.1113/jphysiol.2003.045294
89. Greig, A. V. H., James, S. E., McGrouther, D. A., Terenghi, G., and Burnstock, G. (2003a). Purinergic receptor expression in the regenerating epidermis in a rat model of normal and delayed wound healing. Exp. Dermatol. 12, 860-871. doi: 10.1111/j.0906-6705.2003.00110.x
90. Greig, A. V. H., Linge, C., Healy, V., Lim, P., Clayton, E., Rustin, M. H., et al. (2003b). Expression of purinergic receptors in non-melanoma skin cancers and their functional roles in A431 cells. J. Invest. Dermatol. 121, 315-327. doi: 10.1046/j.1523-1747.2003.12379.x
91. Greig, A. V. H., Linge, C., Terenghi, G., McGrouther, D. A., and Burnstock, G. (2003c). Purinergic receptors are part of a functional signalling system for proliferation and differentiation of human epidermal keratinocytes. J. Invest. Dermatol. 120, 1007-1015. doi: 10.1046/j.1523-1747.2003.12261.x
92. Gu, J. G., and MacDermott, A. B. (1997). Activation of ATP P2X receptors elicits glutamate release from sensory neuron synapses. Nature 389, 749-753. doi: 10.1038/39639
93. + macrophages in rat CNS during experimental autoimmune encephalomyelitis. Neuroscience 134, 199-205. doi: 10.1016/j.neuroscience.2005.04.026
94. Hamilton, S. G., McMahon, S. B., and Lewin, G. R. (2001). Selective activation of nociceptors by P2X receptor agonists in normal and inflamed rat skin. J. Physiol. 534, 437-445. doi: 10.1111/j.1469-7793.2001.00437.x
95. Hansen, M. A., Dutton, J. L., Balcar, V. J., Barden, J. A., and Bennett, M. R. (1999). P2X (purinergic) receptor distributions in rat blood vessels. J. Auton. Nerv. Syst. 75, 147-155. doi: 10.1016/S0165-1838(98)00189-1
96. Hegg, C. C., and Lucero, M. T. (2006). Purinergic receptor antagonists inhibit odorant-induced heat shock protein 25 induction in mouse olfactory epithelium. Glia 53, 182-190. doi: 10.1002/glia.20258
97. Henning, R. H. (1997). Purinoceptors in neuromuscular transmission. Pharmacol. Ther. 74, 115-128. doi: 10.1016/S0163-7258(97)00015-6
98. Hoebertz, A., Arnett, T. R., and Burnstock, G. (2003). Regulation of bone resorption and formation by purines and pyrimidines. Trends Pharmacol. Sci. 24, 290-297. doi: 10.1016/S0165-6147(03)00123-8
99. Housley, G., and Gale, J. (Guest Editors). (2010). Special Issue: Purinergic signalling in the inner ear. Purinergic signal. 6, 149-287. doi: 10.1007/s11302-010-9196-5
100. Housley, G. D. (2000). Physiological effects of extracellular nucleotides in the inner ear. Clin. Exp. Pharmacol. Physiol. 27, 575-580. doi: 10.1046/j.14401681.2000.03314.x
101. Housley, G. D., Bringmann, A., and Reichenbach, A. (2009). Purinergic signaling in special senses. Trends Neurosci. 32, 128-141. doi: 10.1016/j.tins.2009. 01.001
102. Hughes, J. P., Hatcher, J. P., and Chessell, I. P. (2007). The role of P2X7 in pain and inflammation. Purinergic Signal. 3, 163-169. doi: 10.1007/s11302-006-9031-1
103. Inoue, K. (2007). P2 receptors and chronic pain. Purinergic Signal. 3, 135-144. doi: 10.1007/s11302-006-9045-8
104. Inoue, K., Koizumi, S., and Ueno, S. (1996). Implication of ATP receptors in brain functions. Prog. Neurobiol. 50, 483-492. doi: 10.1016/S0301-0082(96)00037-8
105. Jarvis, M. F. (2010). The neural-glial purinergic receptor ensemble in chronic pain states. Trends Neurosci. 33, 48-57. doi: 10.1016/j.tins.2009.10.003
106. 2+ mobilisation, cyclooxygenase and purinergic P2Y1 and P2Y12 receptor activation. Thromb. Haemost. 103, 398-407. doi: 10.1160/TH0907-0442
107. Kawate, T., Michel, J. C., Birdsong, W. T., and Gouaux, E. (2009). Crystal structure of the ATP-gated P2X4 ion channel in the closed state. Nature 460, 592-598. doi: 10.1038/nature08198
108. Knight, G. E., Bodin, P., de Groat, W. C., and Burnstock, G. (2002). ATP is released from guinea pig ureter epithelium on distension. Am. J. Physiol. Renal Physiol. 282, F281-F288. doi: 10.1152/ajprenal.00293.2000
109. Knutsen, L. J. S., and Murray, T. F. (1997). "Adenosine and ATP in epilepsy," in Purinergic Approaches in Experimental Therapeutics, eds K. A. Jacobson and M. F. Jarvis (New York, NY: Wiley-Liss), 423-447.
110. Komarova, S. V., Dixon, S. J., and Sims, S. M. (2001). Osteoclast ion channels: potential targets for antiresorptive drugs. Curr. Pharm. Des. 7, 637-654. doi: 10.2174/1381612013397799
111. Lalo, U., Verkhratsky, A., Burnstock, G., and Pankratov, Y. (2012). P2X receptormediated synaptic transmission. WIREs Membrane Transport and Signaling 1, 297-309. doi: 10.1002/wmts.28
112. Lammas, D. A., Stober, C., Harvey, C. J., Kendrick, N., Panchalingam, S., and Kumararatne, D. S. (1997). ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z (P2X7) receptors. Immunity 7, 433-444. doi: 10.1016/S1074-7613(00)80364-7
113. Lazarowski, E. R. (2012). Vesicular and conductive mechanisms of nucleotide release. Purinergic Signal. 8, 359-373. doi: 10.1007/s11302-012-9304-9
114. Lazarowski, E. R., Sesma, J. I., Seminario-Vidal, L., and Kreda, S. M. (2011). Molecular mechanisms of purine and pyrimidine nucleotide release. Adv. Pharmacol. 61, 221-261. doi: 10.1016/B978-0-12-385526-8.00008-4
115. Lecut, C., Frederix, K., Johnson, D. M., Deroanne, C., Thiry, M., Faccinetto, C., et al. (2009). P2X1 ion channels promote neutrophil chemotaxis through Rho kinase activation. J. Immunol. 183, 2801-2809. doi: 10.4049/jimmunol. 0804007
116. Lee, H. Y., Bardini, M., and Burnstock, G. (2000). Distribution of P2X receptors in the urinary bladder and the ureter of the rat. J. Urol. 163, 2002-2007. doi: 10.1016/S0022-5347(05)67618-5
117. Lemaire, I., Falzoni, S., Leduc, N., Zhang, B., Pellegatti, P., Adinolfi, E., et al. (2006). Involvement of the purinergic P2X7 receptor in the formation of multinucleated giant cells. J Immunol. 177, 7257-7265.
118. Lemaire, I., and Leduc, N. (2004). Purinergic P2X7 receptor function in lung alveolar macrophages: pharmacologic characterisation and bidirectional regulation by Th1 and Th2 cytokines. Drug Dev. Res. 59, 118-127. doi: 10.1002/ddr.10209
119. Lewis, C., Neidhart, S., Holy, C., North, R. A., Buell, G., and Surprenant, A. (1995). Coexpression of P2X2 and P2X3 receptor subunits can account for ATP-gated currents in sensory neurons. Nature 377, 432-435. doi: 10.1038/377432a0
120. Lu, S. H., Fraser, M. O., Chancellor, M. B., Cheng, C. L., and de Groat, W. C. (2002). Voiding dysfunction and purinergic mechanisms in awake chronic spinal cord injured (SCI) rats. Soc. Neurosci. Program No. 68.6.2002.
121. Lucae, S., Salyakina, D., Barden, N., Harvey, M., Gagné, B., Labbé, M., et al. (2006). P2RX7, a gene coding for a purinergic ligand-gated ion channel, is associated with major depressive disorder. Hum. Mol. Genet. 15, 2438-2445. doi: 10.1093/hmg/ddl166
122. Lustig, K. D., Shiau, A. K., Brake, A. J., and Julius, D. (1993). Expression cloning of an ATP receptor from mouse neuroblastoma cells. Proc. Natl. Acad. Sci. USA 90, 5113-5117. doi: 10.1073/pnas.90.11.5113
123. Mantuano-Barradas, M., Henriques-Pons, A., Araújo-Jorge, T. C., Di Virgilio, F., Coutinho-Silva, R., and Persechini, P. M. (2003). Extracellular ATP induces cell death in CD4+/CD8+ double-positive thymocytes in mice infected with Trypanosoma cruzi. Microbes. Infect. 5, 1363-1371. doi: 10.1016/j.micinf.2003.09.017
124. McGaraughty, S., Chu, K. L., Namovic, M. T., Donnelly-Roberts, D. L., Harris, R. R., Zhang, X. F., et al. (2007). P2X7-related modulation of pathological nociception in rats. Neuroscience 146, 1817-1828. doi: 10.1016/j.neuroscience.2007.03.035
125. McLarnon, J. G., Ryu, J. K., Walker, D. G., and Choi, H. B. (2006). Upregulated expression of purinergic P2X7 receptor in Alzheimer disease and amyloid-b peptide-treated microglia and in peptide-injected rat hippocampus. J. Neuropathol. Exp. Neurol. 65, 1090-1097. doi: 10.1097/01.jnen.0000240470.97295.d3
126. Mizumoto, N., Mummert, M. E., Shalhevet, D., and Takashima, A. (2003). Keratinocyte ATP release assay for testing skin-irritating potentials of structurally diverse chemicals. J. Invest. Dermatol. 121, 1066-1072. doi: 10.1046/j.1523-1747.2003.12558.x
127. Mulryan, K., Gitterman, D. P., Lewis, C. J., Vial, C., Leckie, B. J., Cobb, A. L., et al. (2000). Reduced vas deferens contraction and male infertility in mice lacking P2X1 receptors. Nature 403, 86-89. doi: 10.1038/47495
128. Musa, H., Tellez, J. O., Chandler, N. J., Greener, I. D., Maczewski, M., Mackiewicz, U., et al. (2009). P2 purinergic receptor mRNA in rat and human sinoatrial node and other heart regions. Naunyn Schmiedebergs Arch. Pharmacol. 379, 541-549. doi: 10.1007/s00210-009-0403-2
129. Narcisse, L., Scemes, E., Zhao, Y., Lee, S. C., and Brosnan, C. F. (2005). The cytokine IL-1b transiently enhances P2X7 receptor expression and function in human astrocytes. Glia 49, 245-258. doi: 10.1002/glia.20110
130. Nicke, A., Baumert, H. G., Rettinger, J., Eichele, A., Lambrecht, G., Mutschler, E., et al. (1998). P2X1 and P2X3 receptors form stable trimers: a novel structural motif of ligand-gated ion channels. EMBO J. 17, 3016-3028. doi: 10.1093/emboj/17.11.3016
131. North, R. A. (2002). Molecular physiology of P2X receptors. Physiol. Rev. 82, 1013-1067.
132. Nurden, A. T. (2007). Does ATP act through P2X1 receptors to regulate platelet activation and thrombus formation? J. Thromb. Haemost. 5, 907-909. doi: 10.1111/j.1538-7836.2007.02456.x
133. O'Reilly, B. A., Kosaka, A. H., Knight, G. E., Chang, T. K., Ford, A. P. D. W., Rymer, J. M., et al. (2002). P2X receptors and their role in female idiopathic detrusor instability. J. Urol. 167, 157-164. doi: 10.1016/S0022-5347(05)65403-1
134. Orriss, I. R., Burnstock, G., and Arnett, T. R. (2010). Purinergic signalling and bone remodelling. Curr. Op. Pharmacol. 10, 322-330. doi: 10.1016/j.coph.2010.01.003
135. Orriss, I. R., Key, M. L., Brandao-Burch, A., Burnstock, G., and Arnett, T. R. (2012). The regulation of osteoblast function and bone mineralisation by extracellular nucleotides: the role of P2X receptors. Bone 51, 389-400. doi: 10.1016/j.bone.2012.06.013
136. Oses, J. P. (2006). Modification by kainate-induced convulsions of the density of presynaptic P2X receptors in the rat hippocampus. Purinergic Signal. 2, 252-253.
137. Panenka, W., Jijon, H., Herx, L. M., Armstrong, J. N., Feighan, D., Wei, T., et al. (2001). P2X7-like receptor activation in astrocytes increases chemokine monocyte chemoattractant protein-1 expression via mitogen-activated protein kinase. J. Neurosci. 21, 7135-7142.
138. Parvathenani, L. K., Tertyshnikova, S., Greco, C. R., Roberts, S. B., Robertson, B., and Posmantur, R. (2003). P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease. J. Biol. Chem. 278, 13309-13317. doi: 10.1074/jbc.M209478200
139. Pintor, J. (2006). New perspectives in ocular pharmacology: nucleotides as therapeutic agents. An R Acad Nac Farm 72, 519-538.
140. Pintor, J., Peral, A., Pelaez, T., Carracedo, G., Bautista, A., and Hoyle, C. H. (2003). Nucleotides and dinucleotides in ocular physiology: new possibilities of nucleotides as therapeutic agents in the eye. Drug Dev. Res. 59, 136-145. doi: 10.1002/ddr.10193
141. Queiroz, G., Talaia, C., and Gonçalves, J. (2003). ATP modulates noradrenaline release by activation of inhibitory P2Y receptors and facilitatory P2X receptors in the rat vas deferens. J. Pharmacol. Exp. Ther. 307, 809-815. doi: 10.1124/jpet.103.054809
142. Ralevic, V., and Burnstock, G. (1998). Receptors for purines and pyrimidines. Pharmacol. Rev. 50, 413-492.
143. Raouf, R., Chabot-Dore, A. J., Ase, A. R., Blais, D., and Seguela, P. (2007). Differential regulation of microglial P2X4 and P2X7 ATP receptors following LPS-induced activation. Neuropharmacology 53, 496-504. doi: 10.1016/j.neuropharm.2007.06.010
144. Rapaport, E. (1983). Treatment of human tumor cells with ADP or ATP yields arrest of growth in the S phase of the cell cycle. J. Cell. Physiol. 114, 279-283. doi: 10.1002/jcp.1041140305
145. Rappold, P. M., Lynd-Balta, E., and Joseph, S. A. (2006). P2X7 receptor immunoreactive profile confined to resting and activated microglia in the epileptic brain. Brain Res. 1089, 171-178. doi: 10.1016/j.brainres.2006.03.040
146. Roberts, V. H., Webster, R. P., Brockman, D. E., Pitzer, B. A., and Myatt, L. (2007). Post-translational modifications of the P2X4 purinergic receptor subtype in the human placenta are altered in preeclampsia. Placenta 28, 270-277. doi: 10.1016/j.placenta.2006.04.008
147. Rong, W., and Burnstock, G. (2004). Activation of ureter nociceptors by exogenous and endogenous ATP in guinea pig. Neuropharmacology 47, 1093-1101. doi: 10.1016/j.neuropharm.2004.08.003
148. Rong, W., Burnstock, G., and Spyer, K. M. (2000). P2X purinoceptor-mediated excitation of trigeminal lingual nerve terminals in an in vitro intra-arterially perfused rat tongue preparation. J. Physiol. 524, 891-902. doi: 10.1111/j.14697793.2000.00891.x
149. Rossato, M., La Sala, G. B., Balasini, M., Taricco, F., Galeazzi, C., Ferlin, A., et al. (1999). Sperm treatment with extracellular ATP increases fertilization rates in in-vitro fertilization for male factor infertility. Hum. Reprod. 14, 694-697. doi: 10.1093/humrep/14.3.694
150. Ryten, M., Yang, S. Y., Dunn, P. M., Goldspink, G., and Burnstock, G. (2004). Purinoceptor expression in regenerating skeletal muscle in the mdx mouse model of muscular dystrophy and in satellite cell cultures. FASEB J. 18, 1404-1406. doi: 10.1096/fj.03-1175fje
151. Schulman, E. S., Glaum, M. C., Post, T., Wang, Y., Raible, D. G., Mohanty, J., et al. (1999). ATP modulates anti-IgE-induced release of histamine from human lung mast cells. Am. J. Respir. Cell Mol. Biol. 20, 530-537. doi: 10.1165/ajrcmb.20.3.3387
152. Schwiebert, E. M., Wallace, D. P., Braunstein, G. M., King, S. R., Peti-Peterdi, J., Hanaoka, K., et al. (2002). Autocrine extracellular purinergic signaling in epithelial cells derived from polycystic kidneys. Am. J. Physiol. Renal Physiol. 282, F763-F775. doi: 10.1152/ajprenal.0337.2000
153. Shabbir, M., Ryten, M., Thompson, C. S., Mikhailidis, D. P., and Burnstock, G. (2008a). Purinergic receptor-mediated effects of ATP in high-grade bladder cancer. BJU Int. 101, 106-112. doi: 10.1111/j.1464-410X.2007.07286.x
154. Shabbir, M., Thompson, C. S., Jarmulowicz, M., Mikhailidis, D. P., and Burnstock, G. (2008b). Effect of extracellular ATP on the growth of hormone refractory prostate cancer in vivo. BJU Int. 102, 108-112. doi: 10.1111/j.1464410X.2008.07578.x
155. Shen, J. B., Cronin, C., Sonin, D., Joshi, B. V., Gongora Nieto, M., Harrison, D., et al. (2007). P2X purinergic receptor-mediated ionic current in cardiac myocytes of calsequestrin model of cardiomyopathy: implications for the treatment of heart failure. Am. J. Physiol. Heart Circ. Physiol. 292, H1077-H1084. doi: 10.1152/ajpheart.00515.2006
156. Shinoda, M., Feng, B., and Gebhart, G. F. (2009). Peripheral and central P2X3 receptor contributions to colon mechanosensitivity and hypersensitivity in the mouse. Gastroenterology 137, 2096-2104. doi: 10.1053/j.gastro.2009. 06.048
157. Silinsky, E. M., Gerzanich, V., and Vanner, S. M. (1992). ATP mediates excitatory synaptic transmission in mammalian neurones. Br. J. Pharmacol. 106, 762-763. doi: 10.1111/j.1476-5381.1992.tb14408.x
158. Stevenson, R. O., Taylor, R. M., Wiley, J. S., and Sluyter, R. (2009). The P2X7 receptor mediates the uptake of organic cations in canine erythrocytes and mononuclear leukocytes: comparison to equivalent human cell types. Purinergic Signal. 5, 385-394. doi: 10.1007/s11302-009-9163-1
159. Stojilkovic, S. S., He, M. L., Koshimizu, T. A., Balik, A., and Zemkova, H. (2010). Signaling by purinergic receptors and channels in the pituitary gland. Mol. Cell. Endocrinol. 314, 184-191. doi: 10.1016/j.mce.2009.05.008
160. Sugiyama, T., Kobayashi, M., Kawamura, H., Li, Q., Puro, D. G., and Kobayshi, M. (2004). Enhancement of P2X7-induced pore formation and apoptosis: an early effect of diabetes on the retinal microvasculature. Invest. Ophthalmol. Vis. Sci. 45, 1026-1032. doi: 10.1167/iovs.03-1062
161. Takenouchi, T., Iwamaru, Y., Imamura, M., Kato, N., Sugama, S., Fujita, M., et al. (2007). Prion infection correlates with hypersensitivity of P2X7 nucleotide receptor in a mouse microglial cell line. FEBS Lett. 581, 3019-3026. doi: 10.1016/j.febslet.2007.05.057
162. Tempest, H. V., Dixon, A. K., Turner, W. H., Elneil, S., Sellers, L. A., and Ferguson, D. R. (2004). P2X and P2X receptor expression in human bladder urothelium and changes in interstitial cystitis. BJU Int. 93, 1344-1348. doi: 10.1111/j.1464410X.2004.04858.x
163. Tian, G. F., Azmi, H., Takano, T., Xu, Q., Peng, W., Lin, J., et al. (2005). An astrocytic basis of epilepsy. Nat. Med. 11, 973-981. doi: 10.1038/nm1277
164. Trang, T., Beggs, S., and Salter, M. W. (2012). ATP receptors gate microglia signaling in neuropathic pain. Exp. Neurol. 234, 354-361. doi: 10.1016/j.expneurol.2011.11.012
165. Trang, T., and Salter, M. W. (2012). P2X4 purinoceptor signaling in chronic pain. Purinergic Signal. 8, 621-628. doi: 10.1007/s11302-012-9306-7
166. Tsuda, M., Shigemoto-Mogami, Y., Koizumi, S., Mizokoshi, A., Kohsaka, S., Salter, M. W., et al. (2003). P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424, 778-783. doi: 10.1038/nature 01786
167. Tsuda, M., Tozaki-Saitoh, H., and Inoue, K. (2010). Pain and purinergic signaling. Brain Res. Rev. 63, 222-232. doi: 10.1016/j.brainresrev.2009.11.003
168. + rat, a model of autosomal dominant polycystic kidney disease. Cells Tiss. Org. 178, 168-179. doi: 10.1159/000082247
169. Turner, C. M., Tam, F., Lai, P.-C., Tarzi, R. M., Burnstock, G., Pusey, C. D., et al. (2007). Increased expression of the pro-apoptotic ATP-sensitive P2X7 receptor in experimental and human glomerulonephritis. Nephrol. Dial. Transpl. 22, 386-395. doi: 10.1093/ndt/gfl589
170. Unwin, R. J., Bailey, M. A., and Burnstock, G. (2003). Purinergic signaling along the renal tubule: the current state of play. News Physiol. Sci. 18, 237-241. doi: 10.1152/nips.01436.2003
171. Valera, S., Hussy, N., Evans, R. J., Adani, N., North, R. A., Surprenant, A., et al. (1994). A new class of ligand-gated ion channel defined by P2X receptor for extra-cellular ATP. Nature 371, 516-519. doi: 10.1038/371516a0
172. Vanderwinden, J. M., Timmermans, J. P., and Schiffmann, S. N. (2003). Glial cells, but not interstitial cells, express P2X7, an ionotropic purinergic receptor, in rat gastrointestinal musculature. Cell Tiss. Res. 312, 149-154. doi: 10.1007/s00441003-0716-2
173. Vlaskovska, M., Kasakov, L., Rong, W., Bodin, P., Bardini, M., Cockayne, D. A., et al. (2001). P2X3 knockout mice reveal a major sensory role for urothelially released ATP. J. Neurosci. 21, 5670-5677.
174. Volonté, C., and Burnstock, G. (2012). Editorial: pharmacology and therapeutic activity of purinergic drugs for disorders of the nervous system. CNS Neurol. Disord. Drug Targ. 11, 649-651. doi: 10.2174/187152712803581119
175. Vonend, O., Turner, C., Chan, C. M., Loesch, A., Dell'Anna, G. C., Srai, S. K., et al. (2004). Glomerular expression of the ATP-sensitive P2X7 receptor in diabetic and hypertensive rat models. Kidney Int. 66, 157-166. doi: 10.1111/j.15231755.2004.00717.x
176. Wang, J. C., Raybould, N. P., Luo, L., Ryan, A. F., Cannell, M. B., Thorne, P. R., et al. (2003). Noise induces up-regulation of P2X2 receptor subunit of ATP-gated ion channels in the rat cochlea. Neuroreport 14, 817-823. doi: 10.1097/00001756200305060-00008
177. Webb, T. E., Simon, J., Krishek, B. J., Bateson, A. N., Smart, T. G., King, B. F., et al. (1993). Cloning and functional expression of a brain G-protein-coupled ATP receptor. FEBS Lett. 324, 219-225. doi: 10.1016/0014-5793(93)81397-I
178. White, N., and Burnstock, G. (2006). P2 receptors and cancer. Trends Pharmacol. Sci. 27, 211-217. doi: 10.1016/j.tips.2006.02.004
179. White, N., Butler, P. E. M., and Burnstock, G. (2005a). Human melanomas express functional P2X7 receptors. Cell Tiss. Res. 321, 411-418. doi: 10.1007/s00441005-1149-x
180. White, N., Ryten, M., Clayton, E., Butler, P., and Burnstock, G. (2005b). P2Y purinergic receptors regulate the growth of human melanomas. Cancer Lett. 224, 81-91. doi: 10.1016/j.canlet.2004.11.027
181. Wildman, S. S., Kang, E. S., and King, B. F. (2009). ENaC, renal sodium excretion and extracellular ATP. Purinergic Signal. 5, 481-489. doi: 10.1007/s11302-0099150-6
182. Wirkner, K., Sperlagh, B., and Illes, P. (2007). P2X3 receptor involvement in pain states. Mol. Neurobiol. 36, 165-183. doi: 10.1007/s12035-007-0033-y
183. Wynn, G., Bei, M., Ruan, H.-Z., and Burnstock, G. (2004). Purinergic component of mechanosensory transduction is increased in a rat model of colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 287, G647-G657. doi: 10.1152/ajpgi.00020.2004
184. Wynn, G., Rong, W., Xiang, Z., and Burnstock, G. (2003). Purinergic mechanisms contribute to mechanosensory transduction in the rat colorectum. Gastroenterology 125, 1398-1409. doi: 10.1016/j.gastro.2003.07.008
185. Xiang, Z., Bo, X., and Burnstock, G. (1999). P2X receptor immunoreactivity in the rat cochlea, vestibular ganglion and cochlear nucleus. Hear. Res. 128, 190-196. doi: 10.1016/S0378-5955(98)00208-1
186. Xiang, Z., and Burnstock, G. (2004). P2X2 and P2X3 purinoceptors in the rat enteric nervous system. Histochem. Cell Biol. 121, 169-179. doi: 10.1007/s00418004-0620-1
187. Xu, G. Y., Shenoy, M., Winston, J. H., Mittal, S., and Pasricha, P. J. (2008). P2X receptor-mediated visceral hyperalgesia in a rat model of chronic visceral hypersensitivity. Gut 57, 1230-1237. doi: 10.1136/gut.2007.134221
188. Yegutkin, G. G. (2008). Nucleotide-and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade. Biochim. Biophys. Acta 1783, 673-694. doi: 10.1016/j.bbamcr.2008.01.024
189. Yiangou, Y., Facer, P., Baecker, P. A., Ford, A. P., Knowles, C. H., Chan, C. L., et al. (2001). ATP-gated ion channel P2X3 is increased in human inflammatory bowel disease. Neurogastroenterol. Motil. 13, 365-369. doi: 10.1046/j.13652982.2001.00276.x
190. Zhao, D. M., Xue, H. H., Chida, K., Suda, T., Oki, Y., Kanai, M., et al. (2000). Effect of erythromycin on ATP-induced intracellular calcium response in A549 cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 278, L726-L736.
191. Zimmermann, H. (2006). Nucleotide signaling in nervous system devel-opment. Pflugers Arch. 452, 573-588. doi: 10.1007/s00424-0060067-4
192. Zsembery, A., Boyce, A. T., Liang, L., Peti-Peterdi, J., Bell, P. D., and Schwiebert, E. M. (2003). Sustained calcium entry through P2X nucleotide receptor channels in human airway epithelial cells. J. Biol. Chem. 278, 13398-13408. doi: 10.1074/jbc.M212277200